Clinical Trial Update: Oral Multiple-dose Study in Patients With Major Depressive Disorder [Phase 1]

View source ↗

Summary

Phase 1 oral multiple-dose study in adults with Major Depressive Disorder sponsored by Astellas Pharma Inc has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Astellas compound

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED